过去一年中添加的文章，按日期排序
Deletion of Talin1 in Myeloid Cells Facilitates Atherosclerosis in Mice
H Shi, J Song, L Gao, X Shan… - … and vascular biology - pubmed.ncbi.nlm.nih.gov
1 天前 - … atherosclerosis. … atherosclerosis in talin1-deficient mice. Our study provides novel
insights into the roles of myeloid talin1 and integrins in the progression of atherosclerosis. …
insights into the roles of myeloid talin1 and integrins in the progression of atherosclerosis. …
Development of a PCSK9-targeted nanoparticle vaccine to effectively decrease the hypercholesterolemia
Q Fang, X Lu, Y Zhu, X Lv, F Yu, X Ma, B Liu… - Cell Reports …, 2024 - cell.com
3 天前 - … model. Additionally, the vaccine significantly reduces plaque lesion areas in the
aorta and macrophages infiltration in an atherosclerosis mouse model. … and atherosclerosis. …
aorta and macrophages infiltration in an atherosclerosis mouse model. … and atherosclerosis. …
[引用][C] Coagulation factor XI relative to established cardiovascular risk factors and atherosclerosis, in a large middle-aged population
J Alfredsson, B Wegmann, M Holmström… - Thrombosis …, 2024 - thrombosisresearch.com
3 天前 - … of atherosclerosis in a mouse model, indicating a link between FXI and atherosclerosis.
However, there are no previous studies on FXI levels and atherosclerosis severity in …
However, there are no previous studies on FXI levels and atherosclerosis severity in …
Urolithin A promotes atherosclerotic plaque stability by limiting inflammation and hypercholesteremia in Apolipoprotein E–deficient mice
M Xu, J Xu, L Kang, Z Liu, M Su, W Zhao… - Acta Pharmacologica …, 2024 - nature.com
4 天前 - … atherosclerotic lesion development and stability. Apolipoprotein E-deficient (ApoE
−/− ) mice … stress in macrophages and cholesterol influx in atherosclerotic mouse model [54]. …
−/− ) mice … stress in macrophages and cholesterol influx in atherosclerotic mouse model [54]. …
Notoginsenoside R1 decreases intraplaque neovascularization by governing pericyte-endothelial cell communication via Ang1/Tie2 axis in atherosclerosis
Y Li, L Zhang, W Yang, L Lin, J Pan, M Lu… - Phytotherapy … - pubmed.ncbi.nlm.nih.gov
4 天前 - … atherosclerotic plaque vulnerability and decreased the presence of neovessels
in ApoE -/- mice. … R 1 represents a novel therapeutic strategy for atherosclerotic vulnerable …
in ApoE -/- mice. … R 1 represents a novel therapeutic strategy for atherosclerotic vulnerable …
Exploring the Role of ADAM17 in Vascular Smooth Muscle Cells and Macrophages Within the Atherosclerotic Plaque
T Kilic - 2024 - era.library.ualberta.ca
5 天前 - … were purchased from Jackson laboratory and were used to breed our experimental
mice models. Ldlr-/- mice were bred with mice genetically manipulated with the flox …
mice models. Ldlr-/- mice were bred with mice genetically manipulated with the flox …
[HTML][HTML] Mechanism of Zhishi Xiebai Guizhi Decoction to treat atherosclerosis: insights into experiments, network pharmacology and molecular docking
Z Zhang, J Gao, J Wang, Z Mi, H Li, Z Dai, Y Pan… - Journal of …, 2024 - Elsevier
6 天前 - … the model of atherosclerosis, we gave Apolipoprotein E knocked out mice a high-fat
diet. H&E staining was performed to observe the effects of ZSXBGZD on atherosclerosis. …
diet. H&E staining was performed to observe the effects of ZSXBGZD on atherosclerosis. …
Jingzhi Guanxin Oral Liquids Attenuate Atherosclerotic Coronary Heart Disease via Modulating Lipid Metabolism and PPAR-Related Targets
X Wang, T Hu, Y Jiang, Y He, P Li, W Peng, Y Wang… - Pharmaceuticals, 2024 - mdpi.com
7 天前 - … A 24week high-fat diet (HFD) ApoE–/– mice model of atherosclerotic CAD was
established. The therapeutic efficacy was assessed by a series of in vivo experiments, including …
established. The therapeutic efficacy was assessed by a series of in vivo experiments, including …
471-P: Anti-NFKB Inhibitor Beta Antibody Correlates with Cardiovascular Disease in Type 1 Diabetic Patients with Autoimmune Disease
K PARK, L PHAM, Q LI, G YU, J FU… - Diabetes, 2024 - Am Diabetes Assoc
7 天前 - … of ApoE -/- /NOD mice compared to WT mice. These suggest that anti-NFKBIB AAb
is a novel AAb present in people and mouse models with T1D and atherosclerosis, and may …
is a novel AAb present in people and mouse models with T1D and atherosclerosis, and may …
49-OR: GPSM1 Regulates Atherosclerosis Progression by Controlling Macrophage Chemotaxis through PKA/KLF4/PMP22-MAPK Pathway
Y ZHANG, C HU - Diabetes, 2024 - Am Diabetes Assoc
7 天前 - … mice against atherosclerosis and reduces atherosclerotic … knockout mice and
an AAV-PCSK9 injection model. In … induces promotes atherosclerosis development in mice. …
an AAV-PCSK9 injection model. In … induces promotes atherosclerosis development in mice. …